Daniel Skovronsky

(DR. Daniel Skovronsky M.D. Ph.D.)

Currently holds a position at Eli Lilly and Co

Positions

Position Company Period
Senior Vice President, Chief Scientific Officer and President, Lilly Research Laboratories Eli Lilly and Co June 1, 2018 -
Daniel Skovronsky's trades of Eli Lilly and Co's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-12 2025-02-10
PS Planned sale
710 -0.6%
865.76
USD 614,690 		710 -0.6% 865.76 USD 614,690
2025-02-12 2025-02-10
PS Planned sale
340 -0.3%
863.97
USD 293,750 		340 -0.3% 863.97 USD 293,750
2025-02-12 2025-02-10
PS Planned sale
3,950 -3.2%
862.69
USD 3,407,626 		3,950 -3.2% 862.69 USD 3,407,626
2019-10-28 2019-10-25
B Purchase
5,000 +7.1%
108.61
USD 543,050 		5,000 +7.1% 108.61 USD 543,050
// ... existing code ... // ... rest of the file ...